Serum Bilirubin in the Czech Population - Relationship to the Risk of Myocardial Infarction in Males
Abstract
Background: The potential antiatherogenic role of bilirubin is generally acknowledged, so the aim of this study was to determine serum bilirubin concentrations and the prevalence of Gilbert syndrome (GS) in the Czech general population with particular reference to its relationship to the risk of myocardial infarction (MI). Methods and Results: Biochemical markers were analyzed in 2 independent Czech post-MONICA studies (in total, n=3,311), and in 741 male MI patients.
The UGT1A1 promoter gene variant (rs81753472) was analyzed in these MI patients and in the first control population cohort (n=717). Medians of serum bilirubin concentrations in the 2 Czech general population cohorts were 9.6 and 9.8 mu mol/L (10.7 and 11.3 mu mol/L in males, and 8.3 and 8.8 mu mol/L in females; P<0.01).
The prevalence of GS was 8.9%, twice as high in males compared with females (11.6 vs. 6.1%; P<0.01). The UGT1A1 (TA) 7/7 promoter repeats significantly influenced serum bilirubin concentrations in the controls, but not in the MI patients.
Serum bilirubin concentrations were significantly lower in MI patients (7.7 vs. 10.7 mu mol/L; P<0.01), with almost 5-fold lower prevalence of GS. Conclusions: Serum bilirubin concentrations and the prevalence of GS were determined in the Czech general population.
Significantly lower serum bilirubin concentrations were observed in male MI patients.